Physician

Alexander R Gnoy, MD

According to 2025 Medicare claims, Alexander Gnoy, MD (NPI: 1336137827) practices otolaryngology in the Newark, NJ market, with the plurality of this provider's patient population coming from Union, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 07922-2104. Gnoy is affiliated with the Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Gnoy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 613 traditional Medicare patients, billed 997 HCPCS/CPT codes, and received $92,763 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 453 prescription claims across 228 beneficiaries totaling $63,318 in drug costs, led by Ciprofloxacin-Dexamethasone (Ciprofloxacin Hcl/Dexameth). 2023 DME data shows 12 claims. Open Payments data shows 2 records totaling $135. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $17,615 to $63,318. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	491	842	$66,829
2016	472	855	$67,723
2017	532	964	$75,614
2018	465	777	$63,550
2019	446	759	$65,164
2020	436	692	$59,385
2021	524	891	$79,146
2022	516	852	$81,077
2023	514	870	$88,219
2024	613	997	$92,763

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	152	373	$17,615
2016	148	351	$15,508
2017	159	363	$14,156
2018	157	344	$13,706
2019	142	324	$11,021
2020	153	331	$55,754
2021	178	410	$57,350
2022	168	371	$66,996
2023	182	356	$60,015
2024	228	453	$63,318

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$210
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	79	82	$157
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	35	35	$127
31575	Diagnostic exam of voice box using a flexible endoscope	72	73	$108
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	211	211	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	355	441	$72

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	12	136	$1,641
Cefdinir	Cefdinir	52	742	$1,551
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	34	738	$1,096
Famotidine	Famotidine	41	3,604	$829
Fluticasone Propionate	Fluticasone Propionate	44	2,850	$737

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$135	Optinose US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander R. Gnoy, MD?

Tedicare shows public-source Medicare data for Alexander R. Gnoy, MD (NPI 1336137827), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander R. Gnoy, MD have ACO affiliation data?

Alexander R. Gnoy, MD is shown with ACO affiliation data for Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Alexander R. Gnoy, MD?

Alexander R. Gnoy, MD is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Alexander R. Gnoy, MD have Open Payments data?

Alexander R. Gnoy, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.